ID: ALA3086943

Max Phase: Preclinical

Molecular Formula: C42H49N4O10P

Molecular Weight: 800.85

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCc1ccc(-c2cc3cn([C@H]4C[C@H](O)[C@@H](COP(=O)(N[C@@H](C)C(=O)OCc5ccccc5)N[C@@H](C)C(=O)OCc5ccccc5)O4)c(=O)nc3o2)cc1

Standard InChI:  InChI=1S/C42H49N4O10P/c1-4-5-8-13-30-18-20-33(21-19-30)36-22-34-24-46(42(50)43-39(34)56-36)38-23-35(47)37(55-38)27-54-57(51,44-28(2)40(48)52-25-31-14-9-6-10-15-31)45-29(3)41(49)53-26-32-16-11-7-12-17-32/h6-7,9-12,14-22,24,28-29,35,37-38,47H,4-5,8,13,23,25-27H2,1-3H3,(H2,44,45,51)/t28-,29-,35-,37+,38+/m0/s1

Standard InChI Key:  RFXXUKMRZQMNGL-LEOBXKAWSA-N

Associated Targets(Human)

HEL 6614 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Felid alphaherpesvirus 1 460 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human alphaherpesvirus 1 11089 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human alphaherpesvirus 2 4932 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 800.85Molecular Weight (Monoisotopic): 800.3186AlogP: 6.61#Rotatable Bonds: 19
Polar Surface Area: 180.45Molecular Species: NEUTRALHBA: 12HBD: 3
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 13.34CX Basic pKa: 0.11CX LogP: 5.64CX LogD: 5.64
Aromatic Rings: 5Heavy Atoms: 57QED Weighted: 0.05Np Likeness Score: 0.26

References

1. McGuigan C, Bourdin C, Derudas M, Hamon N, Hinsinger K, Kandil S, Madela K, Meneghesso S, Pertusati F, Serpi M, Slusarczyk M, Chamberlain S, Kolykhalov A, Vernachio J, Vanpouille C, Introini A, Margolis L, Balzarini J..  (2013)  Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.,  70  [PMID:24177359] [10.1016/j.ejmech.2013.09.047]

Source